Cytomel is the trade name for the medicine lithiron sodium. It is not a steroid but a thyroid hormone. It is used for medical purposes to combat hypothyroidism, obesity, metabolic disorders and fatigue. It is a synthetically produced thyroid hormone t3 (triiodothyronine). When Cytomel is taken, it increases the patient’s metabolism. The result is faster absorption of proteins, fats and carbohydrates into the body’s cells.
Bodybuilders use this product in cases where excess fat needs to be burned. It is most often used in pre-competitive training as it can be used without monitoring the number of calories consumed. The combination of clenbuterol + cytomel is used quite often and often with positive results. We have also found that when Cytomel is used in a strong professional training course, the course produces better results than a course without Cytomel. This is probably because the proteins are absorbed more quickly into the body.
In any case, you need to be careful when using this drug. Side effects include cardiovascular disease, restlessness, shortness of breath, increased sweating, nausea, headache, mental and metabolic disorders.
When using Cytomel, it is important to increase the dose very gradually. It is not recommended to take more than 25 mcg on the first day and up to 100 mcg on the following days. This helps the body to adapt to the drug.
The daily dose should be divided into several doses at regular intervals. Women are more sensitive to side effects and it is not recommended to exceed the limit of 50 mcg per day. Cytomel withdrawal from intake should also be steady to avoid creating a hormonal bump. The cycle should not exceed 6 weeks. Over prolonged use of certain doses may lead to permanent hypothyroidism. Monitoring of hyperthyroidism by a doctor is also essential, as the use of the drug poses a real risk to life.
Athletes should also not touch the injectable version of the drug, as it is too strong. Generally speaking, t3 is not a drug for beginners in the sport They should start with triacan, then switch to levothyroxine and, if they wish, cytomel.
Orally 30 minutes before meals. For adults, 1/2tab. 50 Berlin-Chemie triiodothyronine per day (equivalent to 25 mcg) is recommended at the start of treatment. It is recommended to increase the dose by 1/2-1 tablet every 2-4 weeks. The average maintenance dose is 1-1.5 tablets of Triiodothyronine 50 Berlin-Chemie.
Allergic reactions, progression of heart failure and angina pectoris.
Contraindications to use
Hypersensitivity to the drug,
Coronary artery disease (myocardial infarction, angina pectoris of functional class III-IV),
untreated adrenal insufficiency,
Caution in tachycardia, tachyarrhythmia, functional class I-II angina pectoris, heart failure, diabetes mellitus and advanced age.
Use during pregnancy and breast-feeding
Triiodothyronine 50 Berlin-Chemie is not recommended for use during pregnancy as part of combination therapy for the treatment of hypothyroidism in combination with thyrostatics as it may lead to fetal hypothyroidism.
Use in elderly patients
Warning: elderly patients.
Careful dose adjustment and frequent monitoring by a physician is necessary in elderly patients with angina pectoris class I-II, heart failure and certain cardiac arrhythmias (tachyarrhythmias).
Overdosage of lithiron, manifested by the development of thyrotoxicosis, especially in functional class I-II angina pectoris, heart failure or tachyarrhythmia, should be avoided. In the case of hypothyroidism due to pituitary insufficiency, it should be checked whether adrenal insufficiency is also present. In this case, treatment of adrenal insufficiency should be started before thyroid hormone therapy.
In therapeutic practice, Cytomel is started at a dose of 25 mcg per day for the treatment of hypothyroidism. After a few weeks, the dose can be increased by a further 25 mcg and, if necessary, up to 75 mcg daily.
For sport, Cytomel doses are similar. The athlete usually starts with a dose of 25 mcg and increases it every 2-4 weeks as needed. For most athletes, the dose should not exceed 75-100 mcg, and in some cases a dose of 125 mcg may be used temporarily.
In terms of duration of use, Cytomel cycles usually last 6-8 weeks. Longer periods (8-12 weeks) are possible, but discontinuation increases the risk of problems.
When discontinuing Cytomel, the athlete should gradually reduce the dose as this will ensure a smooth completion of the cycle. This is done by reducing the maximum dose used during the cycle by 25 mcg periodically for 7-10 days until the product is completely discontinued. Hypothyroidism of any origin: primary and secondary hypothyroidism, including hypothyroidism after hernia surgery, as a consequence of treatment with radioactive iodine or thyrostatics, as a consequence of various inflammations of the thyroid gland.
Prevention of recurrence of nodal hernia after surgery (with normal thyroid function).
Diffuse euthyroid hernia.
Diffuse toxic hernia: after compensation of thyrotoxicosis with thyrostatics (as part of combination therapy).
Thyroid cancer after surgical treatment (to suppress tumour recurrence and as replacement therapy).
As a diagnostic tool in thyroid suppression test.
Use during pregnancy and breastfeeding.
Use should be continued during pregnancy and breastfeeding. During pregnancy, the need for thyroid hormones increases, so dose adjustment is necessary.
However, it is not recommended to use levothyroxine concomitantly with thyroid medications during pregnancy as these cross the placenta and may cause hypothyroidism of the thyroid gland in the fetus. In children, the initial daily dose is 12.5-50 μg. During long-term treatment, the dose is adjusted to approximately 100-150 mcg/m2 body surface area.
Infants and children under 3 years of age are given L-Tyroxine Berlin-Chemie in a single daily dose 30 minutes before the first meal. The tablet should be dissolved in water to a fine suspension which is prepared immediately before administration.
- Thyroid hyperfunction of any origin.
- Untreated adrenocortical insufficiency.
- Acute myocardial infarction.
- Elevated arterial pressure.
- Increased individual sensitivity to the drug.